Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

T cell development, ageing and Interleukin-7.

Richard Aspinall1

  • 1Department of Immunology, Faculty of Medicine, Imperial College London, London SW10 9NH, UK. r.aspinall@imperial.ac.uk

Mechanisms of Ageing and Development
|March 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biologically Younger Individuals, as Identified by MARK-AGE Biological Age Scores, Display a Distinct Favourable Blood Chemistry Profile Regardless of Age.

Aging cell·2026
Same author

Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acid.

BMJ open·2026
Same author

Decompensated Liver Cirrhosis Research Network (UK-CLIF): Building consensus for hepatology trials in the UK.

NIHR open research·2025
Same author

Detection of HHV-5 HHV-6a HHV-6b and HHV-7 in the urine: potential use as a non-invasive diagnostic tool for immune profiling.

Immunity & ageing : I & A·2024
Same author

Quality standards for the management of alcohol-related liver disease: consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology ARLD special interest group.

BMJ open gastroenterology·2023
Same author

UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2022

Interleukin-7 (IL-7) is crucial for T cell development. Its declining levels in aging mice reduce thymus function, and while IL-7 therapy can partially rejuvenate the thymus, it doesn't fully restore youthful function.

Area of Science:

  • Immunology
  • Developmental Biology
  • Aging Research

Background:

  • Interleukin-7 (IL-7) is a vital cytokine for T cell development and maintaining the peripheral T cell pool.
  • IL-7 gene expression in the mouse thymus changes over time, declining significantly with age.
  • This age-related decline in IL-7 is linked to reduced thymic size, cellularity, and T cell output.

Purpose of the Study:

  • To investigate the role of intrathymic Interleukin-7 (IL-7) levels in T cell production throughout aging.
  • To analyze the impact of IL-7 and IL-7 receptor transgenes on T cell development.
  • To understand the limitations of IL-7 therapy in rejuvenating the aging thymus.

Main Methods:

  • Monitoring IL-7 gene expression in the mouse thymus from gestation throughout lifespan.

Related Experiment Videos

  • Analysis of transgenic mice expressing IL-7 or IL-7 receptor transgenes.
  • Evaluating thymic size, cellularity, and T cell output in relation to IL-7 levels.

    • Main Results:

    • IL-7 expression in the thymus decreases measurably with age, correlating with reduced thymic function.
    • Intrathymic IL-7 levels critically influence T cell production, potentially in a non-linear manner.
    • IL-7 therapy in aged animals shows partial thymus rejuvenation but does not restore youthful size or cellularity.

    Conclusions:

    • Age-associated decline in thymic IL-7 impacts T cell homeostasis.
    • The non-linear relationship between IL-7 and T cell production is a key factor in thymic aging.
    • Complete restoration of thymus function via IL-7 therapy may be limited by factors including maintaining therapeutic IL-7 levels.